- Original contribution
- Open Access
Assessing the bioefficacy of conventional solvent and supercritical fluid extracts of green tea to alleviate lifestyle related dysfunctions
Clinical Phytoscience volume 5, Article number: 7 (2019)
Nowadays, consumers are focusing on therapeutic diets that not only serve the purpose of basic nutrition but also possess varied ingredients to fight against free radical mediated malfunctions especially cardiac disorders and type 2 diabetes. In this context, green tea polycatechins need to be introduced in the dietary regimens as per their effective level. Keeping in view, the present study was aimed to assess the hypocholesterolemic and hypoglycemic potential of conventional and supercritical fluid extracted green tea polycatechins, using male Sprague Dawley rats.
The in vivo study was carried out for 60 days to check the response of green tea extract based diets on animal body and serum biomarkers. Three animal trials were conducted; Study I (Normal rats), Study II (hyperglycemic rats) and Study III (hypercholesterolemic rats). Each study was further sectioned into three groups based on dietary modules; control diet, functional diet (enriched with solvent extracted green tea polycatechins) and nutraceutical diet (carrying supercritical fluid extracted green tea polycatechins).
The decrease in cholesterol, triacylglycerol, low density lipoprotein-cholesterol (LDL-c) and glucose was viewed among all groups along with increment in high density lipoproteins-cholesterol (HDL-c) and insulin levels. Furthermore, green tea nutraceutical diet showed an upper hand in ameliorating lifestyle related disorders as compared to functional diet. Though, marked decrement in lipid biomarkers especially cholesterol (15.22%) and LDL-c (20.50%) were found in Study III (hypercholesterolemic rats), whereas highest suppression in glucose (12.71%) and improvement in insulin (8.28%) was obviously recorded in Study II (hyperglycemic rats).
Green tea polycatechins based diets have proven their efficacy in mitigating hypercholesterolemia and hyperglycemia induced by cholesterol and sucrose based dietary regimen.
Nowadays, consumers are shifting their preferences towards such dietary therapies that could tackle the menace of hyperglycemia, hypercholesterolemia and various oncogenic incidences . In this context, diets rich in phytochemicals such as fruits, vegetables, spices and herbs and tea leaves are getting fame [2, 3]. Green tea (Camellia sinensis L.) belongs to Theaceae family, originated from China and converging popularity around the globe since seventeenth century. It carries volatile and non-volatile constituents of Ayurvedic potential . Dried green tea leaves enumerate 30% of polyphenolic molecules. Of the total, 70% of the phytonutrients include epigallocatechin gallate, epicatechin gallate, epigallocatechin, epicatechin and gallocatechin [5, 6].
The term diabetes is characterized by two different metabolic states; IDDM (insulin dependent diabetes mellitus) is directly associated with deteriorated insulin activity due to the damaged islets of Langerhans, whereas NIDDM (non-insulin dependent diabetes mellitus) is linked with abnormal signaling pathway of insulin that increases insulin resistance and reduces glucose conversion to glycogen in liver. In this regard, epigallocatechin gallate mainly avert the pathogenesis of insulin resistance thereby free glucose no longer stays in the blood rather converted to glycogen in the body [7, 8]. Various researchers have also demonstrated increase in the activity of antioxidant enzymes like superoxide dismutase, catalase and glutathione oxidase via green tea extract, ultimately over-coming free-radical induced diseases and related complications [9, 10].
Hypercholesterolemia is a condition i.e. associated with elevated LDL-c level i.e. (bad cholesterol), being low in density, plaque formation in arterial walls, intensifying incidences of angina and heart attack. Conversely, improvement in HDL-c to LDL-c ratio is considered safe . In this context, green tea extract has the ability to inhibit HMG-CoA (3 hydroxy-3-methylglutaryl coenzyme-A) reductase by activating AMP-kinase resultantly modulates cholesterol synthesis in the body cells . Furthermore, epigallocatechin gallate is related with reduced cholesterol absorption in the intestinal lumen .
A clinical trial (32 hyperlipidemias) showed that three cups of green tea (200 mL) per day has the ability to reduce LDL (15.6%), cholesterol (8.36%) and triacylglycerol (18.14%). The reason might be the presence of polycatechins that possess similar response as that of thromboxane (vasodilator). Additionally, galloyl moiety of polycatechins has the potential to regulate hyper-triacylglycerol level to normative values. Besides, green tea has shown its ability to improve HDL-c (9.66%) and apo-A1 while control LDL and apo-B by excreting free lipid bodies without absorption . Further, Brown et al.  found response of epigallocatechin gallate (EGCG) in improving insulin up to 2.97% by deactivating I-kappa kinase i.e. involved in insulin resistance.
Chemicals and procurement of raw material
The diagnostic kits were used from Sigma-Aldrich, Bioassay (Bioassays Chemical Co. Germany) and Cayman Chemicals (Cayman Europe, Estonia). The dried green tea leaves were purchased from the local market. The leaves were ground and enclosed in zip lock bags at room temperature for experimentation.
Preparation of green tea extracts
The conventional solvent extraction (CSE) was prepared by combining dried green tea with binary solvent system at ratio 1:4: HPLC graded water and organic solvent, aqueous acetone (50 v/v). The extract was macerated overnight followed by extraction using orbital shaker (Edmund Buhler Gmg H-Ks 15, Germany) with speed (280 rpm) at 50 min with constant temperature of 50 °C as expressed by Dong et al. . Afterwards, solvent extract was filtered then concentrated using Rotary Evaporator (Eyela, Japan) at 40 ± 5 °C. The catechins were measured as 1325.81 ± 64.85 mg/100 g in dry green tea extract. The supercritical fluid extraction (SFE) of green tea was acquired through SFT-150 system using 99.8% pure CO2 at 50 °C. After the placement of sample in 100 mL extraction vessel, CO2 was liquefied at 3000 psi pressure to accelerate the solvation and mass transfer of the desired active moieties. After a certain duration, extract was obtained in the collecting vial manually after reducing the set pressure. The catechins in green tea supercritical fluid extract were found as 7723 mg/100 g in dry green tea extract .
Sixty male Sprague Dawley rats were acquired from National Institute of Health (NIH), Islamabad, Pakistan and kept in Animal Room of National Institute of Food Science and Technology, University of Agriculture Faisalabad (NIFSAT-UAF), Pakistan. The investigation was carried out in three studies separately (Table 1). Study I comprised of rats fed on normal diet, whereas in study II and III, high glucose and high cholesterol diets were given, respectively. Each group was having 5 rats, though some animals were sacrificed initially to obtain the baseline values. During the entire bioassessment trials, Animal Room was maintained at a temperature and relative humidity of 23 ± 2 °C and 55 ± 5%, respectively. In each study, functional and nutraceutical extract based diets were provided to their respective groups alongside normal diet was fed to normal animals to assess the efficacy of each treatment on the selected parameters; serum lipid profile, glucose and insulin levels. Besides baseline values, the blood was also drawn at 30th day to check the response followed by sacrificing of animals at 60th day. The collected blood in yellow-capped vials was used to probe hyperlipidemic and hyperglycemic perspectives, whereas purple capped vials were employed to assess hematology.
Feed and water intakes
Average feed intake of each group was measured on daily basis by eliminating spilt diet from the total diet given during the whole study period . The water intake for each group was also recorded on daily basis.
Increase in body weight of rats from all experimental groups was measured weekly throughout the study period to analyze the effect of functional and nutraceutical diets on body weight.
Serum lipid profile
Serum cholesterol levels of rats were measured using CHOD-PAP method following the protocol of Elwakkad et al. . Whilst, Low Density Lipoproteins-cholesterol (LDL-c) and High Density Lipoproteins-cholesterol (HDL-c) were determined as described by Alshatwi et al. . Furthermore, triacylglycerol levels in the samples were estimated by liquid triglycerides (GPO-PAP) method as illustrated by Mehra et al. .
Serum glucose and insulin levels
For each study, the collected sera were evaluated for glucose concentration by GOD-PAP instructions as described by Kim et al. , whereas insulin levels of rats were assessed using its respective kits following the method of Ahn et al. .
Red blood cell (RBC) and white blood cell (WBC) counts were determined by the method of Al Haj et al. . While, platelets estimation was carried out as described by Kamatani et al. . The hematological measurements were carried out using Medonic M Series; Boule Diagnostics Int AB Stockholm, Sweden.
The obtained data for each parameter was subjected to statistical modeling through completely randomized design (CRD) using Statistix 8.1. Furthermore, level of significance was also estimated (p < 0.05 and p < 0.01) by using analysis of variance (ANOVA) technique followed by LSD multiple comparison tests for means separation .
Feed and water intakes
The statistical inference for feed intake depicted significant differences due to diets and time frame throughout the trial in all the three studies. The Fig. 1 showed an increasing trend in feed intake however, more increase was observed in normal (control) group in each study. The functional and nutraceutical diets were less consumed as compared to control groups in all the three studies. In study І (Normal rats), the control, functional and nutraceutical diets varied significantly from week 1st to 8th as 13.46 ± 0.62 to 19.23 ± 0.94, 13.02 ± 0.63 to 18.35 ± 0.89 and 12.95 ± 0.62 to 17.87 ± 0.85 g/rat/day, respectively. Likewise, in study ІІ (Hyperglycemic rats) and study ІІІ (Hypercholesterolemic rats), the feed intake varied momentously in control, functional and nutraceutical diets supplemented groups from 14.47 ± 0.71, 14.12 ± 0.65 and 14.01 ± 0.61 to 21.39 ± 1.02, 20.61 ± 1.03 and 20.29 ± 1.02 and 14.01 ± 0.68, 13.84 ± 0.66 and 13.38 ± 0.62 to 20.31 ± 1.01, 19.79 ± 0.96 and 18.99 ± 0.91 g/rat/day, respectively.
The mean squares regarding water intake showed non-momentous variations with respect to diets whilst, differed significantly regarding study duration. The (Fig. 2) demonstrated higher water intake in control groups of all the three studies; study І (Normal rats), study ІІ (Hyperglycemic rats) and study ІІІ (Hypercholesterolemic rats) in contrast to the nutraceutical based diets as observed in feed intake pattern because water to feed ratio remained constant under similar conditions. During 60 days, the mean values for control, functional and nutraceutical diets varied from 19.17 ± 0.92, 18.58 ± 0.89 and 18.1 ± 0.87 to 24.73 ± 1.21, 23.59 ± 1.09 and 22.63 ± 1.07 mL/rat/day in study І, from 20.11 ± 0.97, 19.76 ± 0.93 and 19.25 ± 0.91 to 26.34 ± 1.28, 25.49 ± 1.23 and 24.64 ± 1.21 mL/rat/day in case of study ІІ and from 19.85 ± 0.95, 19.24 ± 0.92 and 18.98 ± 0.93 to 25.81 ± 1.24, 24.63 ± 1.21 and 23.92 ± 1.13 mL/rat/day in study ІІІ, respectively.
The mean squares for body weight depicted significant response with respect to diets and time factor. However, the body weight increased throughout the study as growth was occurring constantly but control groups animals weight was more as compared to nutraceutical diet fed counterparts. In study І (Normal rats), the body weight increased from 135.72 ± 6.47, 134.09 ± 6.57 and 132.89 ± 6.34 to 226.64 ± 11.13, 218.56 ± 10.46 and 208.38 ± 10.01 g/rat/day via control, functional and nutraceutical diets, respectively. Similarly, in case of study ІІ (Hyperglycemic rats) and study ІІІ (Hypercholesterolemic rats), the body weight in the corresponding groups raised substantially from 137.89 ± 6.35, 135.74 ± 6.53 and 134.05 ± 6.42 to 237.17 ± 11.12, 225.32 ± 11.07 and 217.16 ± 10.53 and from 143.03 ± 7.01, 140.54 ± 6.94 and 138.16 ± 6.67 to 258.88 ± 11.98, 243.13 ± 11.19 and 232.1 ± 11.23 g/rat/day as demonstrated in Fig. 3.
The statistical interpretation depicted that diets significantly affected cholesterol level in all the three studies; study І (normal rats), study ІІ (hyperglycemic rats) and study ІІІ (hypercholesterolemic rats) however, time intervals and interaction showed non-significant variance in study І and ІІ except study III. From Day 1 to 60, higher assuaging effect on cholesterol was observed in nutraceutical diet fed groups with reduction of 5.89, 10.32 and 15.22% however, functional diet also proved effective in mitigating cholesterol but at a lesser extent i.e. up to 4.72, 8.52 and 13.15% in all the three studies (study І, ІІ and ІІІ), respectively.
Low density lipoprotein-cholesterol (LDL-c)
The statistical analysis demonstrated significant effect of diets on LDL-c in study І, ІІ and ІІІ whilst, time affected considerably in study ІІ and ІІІ. From initiation to termination of trial, maximum reduction was noted by nutraceutical diet up to 20.5, 12.64 and 6.93% in study ІІІ, ІІ and І followed by functional diet by 18.39, 10.81 and 5.85%, respectively.
High density lipoprotein-cholesterol (HDL-c)
The mean squares expressed non-momentous effects of diets and time interval on HDL-c in study І and ІІ, whereas significant difference was noted in study ІІІ with respect to diets. The functional and nutraceutical diets maximally up-regulated serum HDL-c level up to 2.94 and 3.36% (study ІІІ) followed by 2.61 and 2.85% (study ІІ) and 1.95 and 2.12 (study І), accordingly.
The statistical analysis showed momentous variations on triacylglycerol due to diets in all the three studies І, ІІ and ІІІ. However, time intervals and interactions showed non-significant response throughout the trait. From day 1st to 60th, the decrement in triacylglycerol was viewed by 3.62 and 4.79% (Study І), 6.87 and 8.25% (Study ІІ) and 10.13 and 11.76% (Study ІІI) in functional and nutraceutical diets, respectively.
Mean squares showed significant response of treated diets on glucose levels of rats in study І, ІІ and ІІІ, whereas non-significant differences were observed regarding time intervals and interaction. Throughout the experimentation, the percent reduction in serum glucose in study І, ІІ and ІІІ were up to 5.63, 12.71 and 9.29 via nutraceutical diet and 4.27, 11.63 and 7.64 via functional diet, correspondingly.
The mean squares portrayed significant impact of diets on insulin level of animals however, non-significant influence was viewed with respect to days and interaction. The percent increase in insulin was observed up to 2.56, 6.75 and 4.32 by functional diet and 3.94, 8.28 and 5.51 through nutraceutical diet in study І, ІІ and ІІІ, respectively (Tables 2 and 3).
Red blood cells (erythrocytes)
The mean squares explicated non-momentous increment in red blood cells with respect to diets, time intervals and interaction. Means for red blood cells (Tables 4 and 5) via different diets; control, functional and nutraceutical diets were 7.06 ± 0.34, 6.56 ± 0.3 and 6.90 ± 0.32 cells/pL in study І, 5.17 ± 0.24, 4.9 ± 0.22 and 5.22 ± 0.26 cells/pL in study ІІ and 5.82 ± 0.25, 6.10 ± 0.32 and 5.67 ± 0.24 cells/pL in study ІІІ. Time factor also affected on red blood cells as 6.82 ± 0.38, 6.84 ± 0.31 and 6.86 ± 0.31 cells/pL at Day 1, 30 and 60 in study І that changed to 5.08 ± 0.24, 5.09 ± 0.24 and 5.12 ± 0.25 cells/pL and 5.84 ± 0.27, 5.86 ± 0.29 and 5.89 ± 0.27 cells/pL in study ІІ and ІІІ, accordingly.
White blood cells (lymphocytes)
Statistical scrutiny revealed non-significant response of diets on white blood cells in all the three studies. The control, functional and nutraceutical diets affected on white blood cells (Tables 4 and 5) as 13.22 ± 0.63, 14.14 ± 0.66 and 13.23 ± 0.63 cells/nL in study І, 17.66 ± 0.82, 18.19 ± 0.92 and 17.20 ± 0.78 cells/nL in study ІІ and 14.27 ± 0.65, 15.04 ± 0.73 and 14.29 ± 0.66 cells/nL in study ІІІ, respectively. Time factor showed decline in WBC count from 13.63 ± 0.65 (Day 1) to 13.52 ± 0.60 and 13.44 ± 0.63 cells/nL (at Day 30 and 60) in study І, whereas in study ІІ and ІІІ the WBC count decreased from 17.82 ± 0.86 to 17.67 ± 0.85 and 17.56 ± 0.83 cells/nL and from 14.66 ± 0.66 to 14.54 ± 0.62 and 14.41 ± 0.59 cells/nL from Day 1 to 30 and 60, respectively.
Mean squares indicated non-momentous effect of treatments, time and their interaction on platelets. The control, functional and nutraceutical diets enumerated means for platelets (Tables 4 and 5) as 982.16 ± 47.85, 975.87 ± 49.35 and 975.49 ± 47.62 (103/μL) in study І, 962.84 ± 45.17, 971.13 ± 46.76 and 974.25 ± 48.13 (103/μL) in study ІІ and 940.62 ± 45.27, 961.74 ± 47.31 and 953.79 ± 44.65 (103/μL) in study ІІІ, respectively. Time intervals showed a non-obvious up-regulation in platelets from Day 1 to 30 and 60; from 971.62 ± 47.61 to 978.47 ± 49.38 and 983.43 ± 48.16 (103/μL) in study І, from 962.57 ± 46.53 to 969.61 ± 46.11 and 976.05 ± 47.89 (103/μL) in study ІI and from 943.09 ± 45.79 to 954.92 ± 44.65 and 958.14 ± 46.74 (103/μL) in study ІІІ, respectively.
Previously, Nörnberg et al.  observed that EGCG decreases feed intake due to its interaction with leptin receptors. Furthermore, they found green tea catechins effective in controlling obesity by reducing body weight from 103.2 ± 13.85 to 90.36 ± 17.71 g, by up-regulating thermogenesis or modulating lipolysis, by increasing oxygen uptake and by inhibiting catechol O-methyl transferase (COMT). It also controls fat synthesis by inhibiting enzymes activity. One of their peers, Ortsäter et al.  observed decline in feed intake up to 10–11% in EGCG+diabetic group as compared to control diabetic group. Alongside, they assessed that rats fed on EGCG showed less gain in weight during 6 weeks i.e. 65–77% as compared to control rats i.e. 110%. Earlier, Chan et al.  found decrease (16%) in water intake by those rats that were relying on 5 g of green tea extract, whereas 15 g of green tea extract resulted in more water intake i.e. 55% during 2-weeks trial. Moreover, they viewed that 5 and 15 g of green tea extract reduced the weight gain in animals by 17 and 18% as compared to control rats due to its association in regulating lipid profile. In another scrutiny, it was observed that water intake increases to a significant level in diabetic rats due to the increased thirst response, resulting higher solute saturation in blood disturbing the electrolyte balance . Further, it is found that green tea catechins are astringent in taste hence compels thirst sensation. This fact is supported in the current study where more water intake was observed by positive control group administered with green tea extract in contrast to normal animals.
Earlier, Yang et al.  found reduction in body weight of Sprague Dawley rats by 7.66% by administrating green tea for 25 days. In diabetic control group, increase in body weight is related to increase in triacylglycerol level via sucrose based diet. In contrast, green tea catechins have the ability to suppress glycerol substrate required in the formation of triacylglycerol. In another study, Fukino et al.  found ameliorative ability of green tea extract against triacylglycerol formation up to 16.9% by administrating for 2 months.
Later, Elwakkad et al.  found reduction in serum cholesterol, LDL-c, HDL-c and triacylglycerol levels in obese rats up to 20–55.1, 37.64–55.41, 53.02–45.8 and 20–55.1% via pure EGCG and 14.95–39.95, 21.77–36.8, 26.13–22.52 and 14.95–39.95% via green tea conventional extract supplementation for 5 to 9 weeks, respectively. The management of hypercholesterolemia is based on increase in cholesterol excretion and decrease in its intestinal absorption. Moreover, green tea extract has the potential to down-regulate cholesterol synthesis by the activation of AMP kinase; master enzyme involved in the homeostasis of cellular energy via phosphorylation or deactivation of HMG-CoA (3-hydroxy-3-methylglutaryl-CoA) reductase, a liver enzyme of mevalonate pathway and a major biomarker of cholesterol production. Besides, green tea could suppress hepatic FAS (fatty acid synthesis) and intestinal acetyl Co-A cholesterol acetyl transferase hence cause cholesterol esterification, prevent its absorption. Earlier analysis found non-significant increase in HDL-c i.e. 3.14% via 10 cups of green tea per day . Furthermore, it was noticed that green tea consumption at the rate of 450 mL for 4 weeks could lower cholesterol and LDL-c significantly by 5.18 and 6.25% along with non-momentous increment in HDL-c up to 2.1% .
Later, Al-Attar and Zari  investigated the effect of green tea extract in normoglycemic and hyperglycemic streptozotocin induced albino male rats. After 15 and 30 days, the reduction in cholesterol was observed up to 2.39 and 1.47% in normal rats along with 22.85 and 36.26% decrement in hyperglycemic rats. Moreover, green tea has been found to down-regulate pancreatic lipases that are responsible for triacylglycerol formation resultantly reducing triacylglycerol level up to 3.26% in normal animals while 24.13% in streptozotocin induced diabetic animals. It was also observed in the study that green tea reduces glucose level by 19.89 and 30.88% after 15 and 30 days, respectively in response to insulin stimulated glucose transportation. Afterwards, Haidari et al.  found reduction in serum cholesterol, triacylglycerol, LDL-c and glucose levels at two different doses of green tea extract; 100 and 200 mg/kg up to 4.20 and 17.07%, 10.04 and 33.45%, 4.72 and 19.42% and 5.02 and 38.9% along with increment in HDL-c up to 4.59 and 11.94% in diabetic subjects, correspondingly. The underlying mechanisms include reduction in cholesterol absorption by increasing its fecal excretion and reduction in cholesterol biosynthesis by suppressing enzymatic activity. The green tea polycatechins may reduce glucose formation from non-carbohydrate sources (gluconeogenesis) by decreasing phosphoenol pyruvate carboxykinase from entering into gluconeogenesis. Further, it reduces glucose-6-phosphate breakdown to glucose by down-regulating glucose-6-phosphatase.
One of the scientists group, Hasanein et al.  tested the effect of 1, 2 and 4 mL green tea extract and found reduction in plasma cholesterol by 7.88, 18.2 and 33.23%, triacylglycerol 13.77, 23.79 and 41.74% and LDL-c up to 11.7, 28 and 46%, respectively by up-regulating their excretion or inhibiting cholesterol formation in the liver cells. The EGCG has a modulatory action on acetyl-CoA carboxylase enzyme i.e. indispensable in the formation of acetoacetyl-CoA in the mevalonate pathway. They also found lipid lowering role of green tea by improving HDL-c level by 27.35% via 1 mL of green tea extract i.e. associated with high paraoxonase 1 (PON1) activity. The reduction of serum glucose concentration up to 20.11, 43.97 and 44.84% via 1, 2 and 4 mL of green tea extract after 4 weeks is associated with up-regulation in insulin level or inhibition of α-amylase enzyme in mouth and intestine i.e. related to glucose reduction and energy release. Besides, they determined decrement in feed intake from 15.25 ± 0.758 g (diabetic group) to 15.485 ± 0.435, 15.226 ± 0.524 and 14.683 ± 0.421 g via 1, 2 and 4 mL of green tea extract, respectively resulted in reduced body weight in comparison to control rat group, especially at higher dose of 4 mL.
LDL-c undergoes oxidative modification by macrophages derived from monocytes forming foam cells. The green tea polyphenols have the ability to inhibit LDL-c oxidation by delaying plaque formation. The resistance to LDL-c oxidation was significantly improved by consuming seven to eight cups of 200 mL green tea containing 300 mg of EGCG and ECG up to 1 week [36, 37]. Furthermore, the effect of green tea extract was evaluated on 12 healthy individuals at the rate of 600 mL of green tea/4 weeks that resulted in reduction of oxidized-LDL-c up to 21.15% . The administration of 4.5 g of green tea was observed to reduce LDL-c up to 10 mg/dL during 4 weeks by inhibiting its absorption in the body . Green tea has catechins particularly EGCG 10 μg/mL has the potential to reduce oxidized LDL up to 65% by capturing reactive oxygen species (ROS), controlling the formation of MDA-LDL (malondialdehyde modified-LDL-c) . Afterwards, Nagao et al.  conducted a clinical trial based on two Japanese groups, fed with 22 and 690 mg of catechins per day for 12 weeks. The study resulted in reduction of malondialdehyde-modified LDL (13.96%) due to thermogenic effect of EGCG and catechins. Moreover, green tea catechins at the rate of 690 mg/day resulted in 7.5% increase in insulin release from 67.5 ± 5.2 to 72.6 ± 10.5 picomol/L. However, non-significant effects were recorded on blood indices as indicated in the current research.
Mehra et al.  found decrease in cholesterol synthesizing enzymes up to 11, 25 and 20% in high cholesterol plus high sugar diet fed animals by supplementing catechins based diet for 4, 8 and 12 weeks, respectively. Alongside, they also found decrease in LDL-c along with increase in HDL-c. This is because green tea overcomes the detrimental symptoms associated with high fat diet, inducing lipogenesis by stimulating acetyl-CoA carboxylase and fatty acid synthase (FAS). Another mechanism involved is the induction of thermogenesis process by green tea i.e. consuming oxygen and increasing energy expenditure by 3 to 4%. In the similar study, they expounded therapeutic effects of green tea against type 2 diabetes by enhancing insulin activated GLUT4 transport. The obese rats were having 57% high plasma glucose concentration as compared to normal rats. However, catechin+high fat and sugar diet showed 9.6% reduction as compared to positive control. The mechanism explains that EGCG has insulin potentiating activity that increases glucose uptake by fat cells however, decreases glucose absorption through intestinal cells by preventing Na-dependent glucose transportation (SGLT1).
Another analysis investigated the therapeutic potential of different doses of EGCG (0.25, 0.5 and 1%) that responded dose dependent decline in glucose up to 2.42, 21.6 and 36.87% in mice and 15.8% in rats at 0.5% dose. They also noted increment in insulin response in diabetic and obese subjects from 0.14 (control) to 0.96 nmol/L by a dose of 1% EGCG. Likewise, they found triacylglycerol suppression by 26, 29 and 63% via 0.25, 0.5 and 1% EGCG however, 18.98% decrease in rats at the rate of 0.5% EGCG. The reduction in glycerol-3-phosphate acyl transferase could be a possible inhibitory mechanism involved . Furthermore, Kao et al.  indicated reduction in serum cholesterol from 83 ± 0.8 to 69 ± 2.2 mg/dL in Sprague Dawley rats within 7 days. However, triacylglycerol and glucose level was observed to reduce by 45.8 and 31.81%. EGCG is associated with reduced triacylglycerol level by reducing the fatty acid synthesizing enzymes or by increasing the fecal excretion of sterols. Additionally, they studied the effect of two dominant catechins of green tea on red blood cells count (106/μL) and found increment from 6.51 ± 0.11 (control) to 7.40 ± 0.23 via ECG and 7.90 ± 0.15 via EGCG. The higher RBC content has been positively associated with increased hemoglobin level from 13.7 ± 0.46 g/dL (control) to 15.5 ± 0.45 g/dL via ECG and16.8 ± 0.46 g/dL with EGCG. They also observed decrease in WBC (103/μL) from 11.03 ± 1.39 to 9.40 ± 1.00 by ECG and 9.92 ± 0.19 via EGCG. It was also found in the same study that neutrophils (anti-inflammatory) increased but other indices of WBC including lymphocytes, monocytes and esinophils decreased non-significantly. Moreover, ECG and EGCG resulted in increase of platelets from 950 ± 80 to 1325 ± 96 (103/μL) via ECG and 1942 ± 59 (103/μL) through EGCG. Later, Batista et al.  studied the decrease in total cholesterol by 3.9% and LDL up to 4.5% in 33 dyslipidemias during 8 weeks by feeding green tea dry extract in-combination with low cholesterol diet. However, reduction in triacylglycerol level was viewed after 16 weeks.
In an animal trial, Islam and Choi  observed the significant reduction in lipid and glucose profile of diabetic Sprague Dawley rats at higher dose of green tea diet (2%) in contrast to low green tea diet (0.5%). The green tea polyphenols hence reduced the LDL-c and triacylglycerol up to 24 and 46.66% in diabetic rats after 4 weeks, respectively. The triacylglycerol reduction is attributed to decreased triacylglycerol absorption in the gut system. Furthermore, green tea possesses insulinotropic (insulin like) effects, raising insulin secretion. They found lower dose of green tea more effective in managing the body weight. In the study, it was also clarified that higher EGCG consumption resulted in reduced feed consumption as compared to positive control diabetic animals. On the other hand, they noticed higher feed intake in diabetic rats relying on lower dose (0.5%) of green tea that resulted in higher liver glycogen and liver weight. Besides, higher amounts of EGCG (i.e. 2%) may cause cytotoxicity hence decreasing the desire for food. Later, Sabahelkhier et al.  found that aqueous extract of green tea (12%) significantly reduced body weight 47.6%, cholesterol 59.9%, triacylglycerol 32% and glucose 47.61% in American white rats. The reduction in lipidemic parameters cut-down the risk of cardiovascular events and increase in glucose uptake by fat cells due to insulin potentiating effect is attributed to green tea extract. Further investigation ascribed the positive role of green tea against renal dysfunctions in response to hyperlipidemic and hyperglycemic conditions.
Earlier findings supported that green tea extract (500 mg/day) improved insulin by 4.89% hence correcting type-2 diabetes . The anti-insulin resistant activity of green tea extract especially EGCG has been studied in rats. It has been found that green tea extract at the rate of 1 to 2 g/kg diet for 6 weeks possesses insulin potentiating activity up to 5.6% in experimental rats or it might be associated with correction of impaired β-cell functioning. Thus, green tea extract balances between hyperinsulinemia and hyperglycemia for the homeostatic control of blood glucose level . Further analysis showed that EGCG 200 mg/kg/day for 12 weeks reduced plasma glucose load up to 15% by increasing insulin sensitivity up to 13% . Similarly, Chan et al.  elucidated 15% increase in insulin level by supplementing green tea to 34 obese Chinese female subjects for 3 months.
Additionally, Chengelis et al.  observed the safety of green tea catechins on the experimental animals. The RBCs (106/μL) raised from 7.89 ± 0.264 (control) to 8.30 ± 0.432, 8.56 ± 0.436, 8.63 ± 0.337 and 8.15 ± 0.388 at the rate of 500, 1000, 2000 mg/kg/day of green tea and 2000 mg/kg/day of decaffeinated green tea, respectively as observed in the current investigation. The decaffeinated green tea extract at the rate of 2000 mg/kg/day during 28 days resulted in reduced WBCs from 10.27 ± 2.828 (control) to 10.17 ± 1.518 (× 103/μL) i.e. decrease up to 0.97% in male and 2.7% in female subjects from 8.77 ± 1.420 to 8.53 ± 1.518 (× 103/μL). This has resulted in non-significant reduction due to the non-momentous rise in neutrophils and monocytes only. Although, most WBC indices like lymphocytes, esinophils and basophils showed a decreasing trend. Moreover, the platelet count (103/μL) observed an inclining trend from 1013 ± 112.8 (control) to 1013 ± 174.5 in male and from 1125 ± 137.7 (control) to 1159 ± 254 in female subjects as viewed in the present study. However, green tea extract at 500 and 1000 mg/kg/day resulted in increased platelet count up to 1154 ± 139.4 and 1046 ± 158.6 and 1139 ± 97.0 and 1162 ± 150.8 (103/μL) in males and female subjects as compared to control, respectively. One of their peers, Matsuyama et al.  carried out an experimental trial on 40 obese Japanese children administrated with green tea at the rate of 75 (control group) and 576 (catechin group) mg/day for 24 weeks that showed increased RBCs in both groups from 492.7 ± 7.4 (× 1010/L) at 0 day to 496.7 ± 8.7 (× 1010/L) at 24th week in catechin group and from 490.2 ± 7.6 (× 1010/L) at 0 day to 496.9 ± 7.3 (× 1010/L) at 24th week in control group by increasing the hemoglobin content. They also found increase in platelets content at the rate of 75 mg/day during 24 weeks from 32.5 ± 1.48 to 33.05 ± 1.57 × 1010/L. Another meta-analysis on rats and dogs confirmed the non-toxic effects of green tea at the rate of 500 mg/kg/day after 13 weeks. The RBCs were found to increase from 7.62 ± 0.468 106/μL (control) to 7.63 ± 0.467 106/μL at the rate of 500 mg/kg/day in rats with the non-significant increase in hemoglobin content. Moreover, EGCG at the rate of 500 mg/kg/day after 13 weeks resulted in reduction of WBCs 3.29% from 9.1 ± 1.55 to 8.4 ± 1.331 (× 103/μL) in female rats. However, increase in platelets from 1060 ± 78 (control) to 1127 ± 113 (× 103/μL) was viewed in experimented rats at the rate of 150 mg EGCG/kg/day .
In a nutshell, green tea extract has shown the ability to reduce hyperglycemia and lipidemic profile except HDL-c, alongside green tea catechins portrayed insulin mimetic effects. Comparison of extracts clarified that extract achieved via supercritical fluid extraction mode (nutraceutical diet) was more effective against altered biomarkers as compared to conventional solvent extracted counterpart (functional diet). Conclusively, the study proved that extracted green tea polycatechins could be introduced in routine menu to attain the optimal health benefits and to fight against lifestyle mediated maladies.
Conventional Solvent Extraction
Fatty Acid Synthesis
High Density Lipoproteins-Cholesterol
3 Hydroxy-3-Methylglutaryl Coenzyme-A Reductase
Insulin Dependent Diabetes Mellitus
Low Density Lipoprotein-Cholesterol
Non-Insulin Dependent Diabetes Mellitus
Red Blood Cell
Supercritical Fluid Extraction
Na-Dependent Glucose Transportation
White Blood Cell
Patil L, Balaraman R. Effect of green tea extract on doxorubicin induced cardiovascular abnormalities: antioxidant action. Iran J Pharm Res. 2011;10(1):89–96.
Chaturvedi S, Sharma PK, Vipin KG, Mayank B. Role of nutraceuticals in health promotion. Health. 2011;3(1):442–8.
Yadav V, Love S, Binny T, Moza AH. An overview on nutraceuticals as pharmacological agents. Adv Biores. 2012;3(3):113–28.
De-Mejia EG, Marco VR, Sirima P. Bioactive components of tea: Cancer, inflammation and behavior. Brain Behav Immun. 2009;23(6):721–31.
Cabrera C, Artacho R, Gimenez R. Beneficial effects of green tea-a review. J Am Coll Nutr. 2006;25(2):79–99.
Ogle N. Green tea Camellia sinensis. Aust J Med Herb. 2009;21(2):44–8.
Sadek KM. Hypoglycemic effect of green tea in experimentally induced diabetic rats. J Pharmacol Toxicol. 2011;1(6):7–9.
Brown AL, Joan L, Jacqueline C, Janice S, Sarah J, Alison S, Les B, Andy C, Hilde H. Effects of dietary supplementation with the green tea polyphenol epigallocatechin-3-gallate on insulin resistance and associated metabolic risk factors: randomized controlled trial. Br J Nutr. 2009;101(6):886–94.
Babu PVA, Sabitha KE, Shyamaladevi CS. Green tea impedes dyslipidemia, lipid peroxidation, protein glycation and ameliorates Ca2+-ATPase and Na+/K+-ATPase activity in the heart of streptozotocin-diabetic rats. Chem Biol Interact. 2006;162(2):157–64.
Roghani M, Tourandokht B. Hypoglycemic and hypolipidemic effect and antioxidant activity of chronic epigallocatechin-gallate in streptozotocin-diabetic rats. Pathophysiology. 2010;17(1):55–9.
Sinija VR, Mishra HN. Green tea: health benefits. J Nutr Environ Med. 2008;17(4):232–42.
Singh DK, Subhashis B, Todd DP. Green and black tea extracts inhibit HMG-CoA reductase and activate AMP-kinase to decrease cholesterol synthesis in hepatoma cells. J Nutr Biochem. 2010;20(10):816–22.
Bursill CA. Roach PD. a green tea catechin extract upregulates the hepatic low-density lipoprotein receptor in rats. Lipids. 2007;42(7):621–7.
Dong J, Jian-Hui Y, Jian-Liang L, Xin-Qiang Z, Yue-Rong L. Isolation of antioxidants catechins from green tea and its decaffeination. Food Bioprod Process. 2011;89(1):62–6.
Ghoreishi SM, Heidari E. Extraction of epigallocatechin gallate from green tea via modified supercritical CO2: experimental, modeling and optimization. J Supercrit Fluids. 2012;72(1):8426–46.
Wolf BW, Weisbrode SE. Safety evaluation of an extract from Salacia oblonga. Food Chem Toxicol. 2003;41(6):867–74.
Elwakkad ASE, Diaa BA, Saadia M, Salwa RE, Mohamed AH. The enhancement effect of administration of caffeine in combination with green tea and its component on lipid profile elements in obese rats. N Y Acad Sci. 2012;5(6):30–7.
Alshatwi AA, Al-Obaaid MA, Al-Sedairy SA, Al-Assaf AH, Zhang JJ, Lei KY. Tomato powder is more protective than lycopene supplement against lipid peroxidation in rats. Nutr Res. 2010;30(1):66–73.
Mehra P, Ashwani K, Devi DB. Studies on the development of a non-genetic obese type 2 diabetic rat model: amelioration by (+)-catechin hydrate. Am. J Biomed Sci. 2010;2(4):235–6.
Kim JI, Paik JK, Kim OY, Park HW, Lee JH, Jang Y, Lee JH. Effects of lycopene supplementation on oxidative stress and markers of endothelial function in healthy men. Atherosclerosis. 2011;215(1):189–95.
Ahn J, Choi W, Kim S, Ha T. Anti-diabetic effect of watermelon (Citrullus vulgaris Schrad) on streptozotocin-induced diabetic mice. Food Sci Biotechnol. 2011;20(1):251–4.
Al Haj M, Kazzam E, Nagelkerke NJ, Nyberg F, Nicholls MG, Adem A. Effect of dehydration in the presence and absence of the angiotensin receptor blocker losartan on blood constituents in the camel. Hamdan. Med J. 2011;4(2):73–8.
Kamatani Y, Matsuda K, Okada Y, Kubo M, Hosono N, Daigo Y, Nakamura Y, Kamatani N. Genome-wide association study of hematological and biochemical traits in a Japanese population. Nature Genet. 2010;42(3):210–5.
Mason RL, Gunst RF, Hess JL. Statistical design and analysis of experiments. Hoboken, NJ: John Wiley and Sons, Inc.; 2003.
Nörnberg FR, Fernanda AD, Rafael AT, Magna DGSL, Elessandra DRZ, Alvaro RGD, Elizabete H. The 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical scavenging activities of green, red and white teas and their effects on the lipid profiles of rats. J Med Plants Res. 2012;6(10):2033–40.
Ortsäter H, Nina G, Swen W, Nicolas K, Ake S. Diet supplementation with green tea extract epigallocatechin gallate prevents progression to glucose intolerance in db/db mice. Nutr Metab. 2012;9(11):1–10.
Chan PT, Fong WP, Cheung YL, Huang Y, Ho WKK, Chen ZY. Jasmine green tea epicatechins are hypolipidemic in hamsters (Mesocricetus auratus) fed a high fat diet. J Nutr. 1999;129(6):1094–101.
Islam MS. Effects of the aqueous extract of white tea (Camellia sinensis) in a streptozotocin-induced diabetes model of rats. Phytomedicine. 2011;19(1):25–31.
Yang MH, Cheng HW, Hsiao LC. Green, oolong and black tea extracts modulate lipid metabolism in hyperlipidemia rats fed high-sucrose diet. J Nutr Biochem. 2001;12(1):14–20.
Fukino Y, Ikeda A, Maruyama K, Aoki N, Okubo T, Iso H. Randomized controlled trial for an effect of green tea-extract powder supplementation on glucose abnormalities. Eur J Clin Nutr. 2008;62(8):953–60.
Tokunaga S, White I, Frost C, Tanaka K, Kono S, Tokudome S, Akamatsu T, Moriyama T, Zakouji H. Green tea consumption and serum lipids and lipoproteins in a population of healthy workers in Japan. Ann Epidemiol. 2002;12(3):157–65.
Duffy SJ, Joseph AV, Monika H, Peter LS, John FK. Effect of acute and chronic tea consumption on platelet aggregation in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2001;21(6):1084–9.
Al-Attar AM, Zari TA. Influences of crude extract of tea leaves, Camellia sinensis, on streptozotocin diabetic male albino mice. Saudi J Biol Sci. 2010;17(4):295–301.
Haidari F, Majid MS, Mehdi Z, Hossein R, Kosar O. Effect of green tea extract on body weight, serum glucose and lipid profile in streptozotocin-induced diabetic rats. A dose response study. Saudi Med J. 2012;33(2):128–33.
Hasanein MA, Soha H, Abdel G, Ashraf AA. Effect of water extract prepared from green tea, black tea and cinnamon on obese rats suffering from diabetes. WASJ. 2012;20(7):976–87.
Miura Y, Tsuyoshi C, Shinji M, Isao T, Keizo U, Masahiko I, Takako T. Green tea polyphenols (flavan 3-ols) prevent oxidative modification of low density lipoproteins: an ex vivo study in humans. J Nutr Biochem. 2000;11(4):216–22.
Kasaoka S, Koji H, Tatsuya M, Shuhachi K. Green tea flavonoids inhibit the LDL oxidation in osteogenic disordered rats fed a marginal ascorbic acid in diet. J Nutr Biochem. 2002;13(2):96–102.
Sung H, Won-Ki M, Woochang L, Sail C, Hyosoon P, Yong-Wha L, Seongsoo J, Do-Hoon L. The effects of green tea ingestion over four weeks on atherosclerotic markers. Ann Clin Biochem. 2005;42(4):292–7.
Gomikawa S, Ishikawa Y, Hayase W, Haratake Y, Hirano N, Matuura H, Mizowaki A, Murakami A, Yamamoto M. Effect of ground green tea drinking for 2 weeks on the susceptibility of plasma and LDL to the oxidation ex vivo in healthy volunteers. Kobe J Med Sci. 2008;54(1):62–72.
Yang TTC, Koo MWL. Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation. Atherosclerosis. 2000;148(1):67–73.
Nagao T, Komine Y, Soga S, Meguro S, Hase T, Tanaka Y, Tokimitsu I. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 2005;81(1):122–9.
Wolfram S, Daniel R, Mareike P, Ying W, Sandra RT, Christoph R, Peter W. Epigallocatechin gallate supplementation alleviates diabetes in rodents. J Nutr. 2006;136(10):2512–8.
Kao K, Richard AH, Shutsung L. Modulation of endocrine systems and food intake by green tea epigallocatechin gallate. Endocrinology. 2000;141(3):980–7.
Batista GAP, Da Cunha CLP, Scartezini M, Von der Heyde R, Bitencourt MG, De Melo SF. Prospective double-blind crossover study of Camellia sinensis (green tea) in dyslipidemias. Arq Bras Cardiol. 2009;93(2):121–7.
Islam MS, Choi H. Green tea, anti-diabetic or diabetogenic: a dose response study. Biofactors. 2007;29(1):45–53.
Sabahelkhier MK, Sulafa HN, Mohammed NM, Wese AS, Amani AE, Mehad AF. Effects of aqueous extraction of green tea (Camellia sinensis) on some biochemical parameters in American white rats. J Anim Plant Sci. 2012;13(1):1725–30.
Mirzaei K, Hossein NA, Javad HAM, Jafari N, Najmafshar A, Mohammadzadeh N, et al. Visfatin genotype may modify the insulin resistance and lipid profile in type 2 diabetes patients. Minerva Endocrinol. 2009;34(4):273–9.
Hininger-Favier I, Rachida B, Sara C, Richard AA, Anne-Marie R. Green tea extract decreases oxidative stress and improves insulin sensitivity in an animal model of insulin resistance, the fructose-fed rat. J Am Coll Nutr. 2009;28(4):355–61.
Venables MC, Hulston CJ, Cox HR, Jeukendrup AE. Green tea extracts ingestion, fat oxidation, and glucose tolerance in healthy humans. J Am Coll Nutr. 2008;87(3):778–84.
Chan CCW, Marcel WLK, Ernest HYN, Oi-Shan T, William SBY, Pak-Chung H. Effects of Chinese green tea on weight, and hormonal and biochemical profiles in obese patients with polycystic ovary syndrome -a randomized placebo-controlled trial. J Soc Gynecol Investig. 2006;13(1):63–8.
Chengelis CP, Kirkpatrick JB, Regan KS, Radovsky AE, Beck MJ, Morita O, Tamaki Y, Suzuki H. 28-day oral (gavage) toxicity studies of green tea catechins prepared for beverages in rats. Food Chem Toxicol. 2008;46(3):978–89.
Matsuyama T, Tanaka Y, Kamimaki I, Nagao T, Tokimitsu I. Catechin safely improved higher levels of fatness, blood pressure, and cholesterol in children. Obesity. 2008;16(6):1338–48.
Isbrucker RA, Edwards JA, Wolz E, Davidovich A, Bausch J. Safety studies on epigallocatechin gallate (EGCG) preparations. Part 2: dermal, acute and short-term toxicity studies. Food Chem Toxicol. 2006;44(5):636–50.
The authors are thankful to Functional and Nutraceutical Food Research Section, National Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan.
This research was partially supported by Higher Education Commission, Pakistan under Pak-US Science and Technology Cooperation Program Phase IV (Project Grant No. 10/01/10–09/30/12), project entitled “Establishment of Functional and Nutraceutical Food Research Section at the National Institute of Food Science and Technology, University of Agriculture, Faisalabad, Pakistan”.
Availability of data and materials
Ethics approval was provided by the head of the NIFSAT-UAF, Pakistan, by reviewing the plans of Animal Experimentation Ethics Committee, UAF. The care of animals during experimentation were as per the instructions provided by the committee and the university.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ashfaq, F., Butt, M.S., Bilal, A. et al. Assessing the bioefficacy of conventional solvent and supercritical fluid extracts of green tea to alleviate lifestyle related dysfunctions. Clin Phytosci 5, 7 (2019) doi:10.1186/s40816-019-0102-6
- Functional diet
- Nutraceutical diet
- Green tea
- Solvent extract
- Supercritical fluid extract
- Sprague Dawley rats